Danaher Co. (NYSE:DHR) Shares Acquired by Toroso Investments LLC

Toroso Investments LLC increased its stake in shares of Danaher Co. (NYSE:DHRGet Rating) by 8.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,289 shares of the conglomerate’s stock after buying an additional 1,756 shares during the quarter. Toroso Investments LLC’s holdings in Danaher were worth $6,538,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. GHP Investment Advisors Inc. purchased a new position in shares of Danaher during the first quarter worth about $26,000. Lloyd Advisory Services LLC. purchased a new position in shares of Danaher during the first quarter worth about $26,000. Landmark Wealth Management LLC purchased a new position in shares of Danaher during the first quarter worth about $32,000. Lansing Street Advisors purchased a new position in shares of Danaher during the first quarter worth about $34,000. Finally, American National Bank purchased a new position in shares of Danaher during the first quarter worth about $35,000. Hedge funds and other institutional investors own 77.27% of the company’s stock.

Danaher Trading Down 0.0 %

Shares of Danaher stock opened at $281.73 on Thursday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.75 and a quick ratio of 1.32. Danaher Co. has a 1 year low of $233.71 and a 1 year high of $331.68. The company has a market capitalization of $204.94 billion, a P/E ratio of 33.18, a P/E/G ratio of 1.39 and a beta of 0.88. The business has a 50 day moving average price of $278.50 and a 200 day moving average price of $269.73.

Danaher (NYSE:DHRGet Rating) last issued its quarterly earnings data on Thursday, July 21st. The conglomerate reported $2.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.35 by $0.41. Danaher had a return on equity of 18.57% and a net margin of 20.61%. The firm had revenue of $7.75 billion during the quarter, compared to the consensus estimate of $7.29 billion. During the same period in the previous year, the firm posted $2.46 EPS. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. Sell-side analysts anticipate that Danaher Co. will post 10.4 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, September 30th will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 0.35%. Danaher’s dividend payout ratio is currently 11.78%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on DHR shares. Robert W. Baird lifted their price objective on Danaher from $319.00 to $325.00 in a report on Friday, July 22nd. UBS Group lifted their price objective on Danaher from $297.00 to $323.00 and gave the company a “buy” rating in a report on Thursday, July 28th. StockNews.com raised Danaher from a “buy” rating to a “strong-buy” rating in a report on Friday, August 26th. Sanford C. Bernstein started coverage on Danaher in a report on Tuesday, August 16th. They issued an “outperform” rating and a $340.00 price objective on the stock. Finally, Barclays lifted their price objective on Danaher from $290.00 to $310.00 in a report on Friday, July 22nd. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Danaher has an average rating of “Buy” and an average target price of $320.73.

Insider Buying and Selling

In related news, CEO Rainer Blair sold 25,000 shares of Danaher stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $7,500,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,739 shares in the company, valued at approximately $23,921,700. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Danaher news, CEO Rainer Blair sold 25,000 shares of the business’s stock in a transaction on Monday, August 15th. The stock was sold at an average price of $300.00, for a total value of $7,500,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,739 shares in the company, valued at approximately $23,921,700. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Joakim Weidemanis sold 12,000 shares of the business’s stock in a transaction on Monday, July 25th. The shares were sold at an average price of $271.13, for a total value of $3,253,560.00. Following the completion of the transaction, the executive vice president now owns 74,398 shares of the company’s stock, valued at $20,171,529.74. The disclosure for this sale can be found here. Insiders sold 40,906 shares of company stock worth $11,823,179 in the last ninety days. Insiders own 11.20% of the company’s stock.

Danaher Company Profile

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.